Propofol 2%: understanding a new concentration of a well-known medication

Betsy A Regier^{1

2}, Tricia A Meyer^{2

3}, Russell K McAllister^{1

2}

Affiliations

¹ Department of Anesthesiology, Baylor Scott & White Medical Center - Temple, Temple, Texas.
² Department of Anesthesiology, Texas A&M College of Medicine, Temple, Texas.
³ Department of Pharmacy, Baylor Scott & White Medical Center - Temple, Temple, Texas.

Betsy A Regier et al. Proc (Bayl Univ Med Cent). 2021.

. 2021 Jun 17;34(5):642-643.

doi: 10.1080/08998280.2021.1937009. eCollection 2021 Sep.

Betsy A Regier^{1

2}, Tricia A Meyer^{2

3}, Russell K McAllister^{1

2}

¹ Department of Anesthesiology, Baylor Scott & White Medical Center - Temple, Temple, Texas.
² Department of Anesthesiology, Texas A&M College of Medicine, Temple, Texas.
³ Department of Pharmacy, Baylor Scott & White Medical Center - Temple, Temple, Texas.

No abstract available

References

1. Erden IA, Gülmez D, Pamuk AG, Akincia SB, Hasçelik G, Aypar U.. The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do not. Braz J Anesthesiol. 2013;63(6):466–472. doi:10.1016/j.bjane.2012.10.003. - DOI - PubMed
1. US Food and Drug Administration . Propoven 2% fact sheet for health care providers. https://www.fda.gov/media/137889/download. Accessed May 15, 2021.
1. Sato K, Kamii H, Kato M.. Effect of 1% and 2% propofol in MCT/LCT emulsion on serum lipids. J Neurosurg Anesthesiol. 2006;18(4):301.
1. Barrientos-Vega R, Sánchez-Soria MM, Morales-Garcia C, Cuena-Boy R, Castellano-Hernández M.. Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med. 2001;29(2):317–322. doi:10.1097/00003246-200102000-00018. - DOI - PubMed
1. Truitt E, Thompson R, Blazey-Martin D, NiSai D, Salem D.. Effect of the implementation of barcode technology and an electronic medication administration record on adverse drug events. Hosp Pharm. 2016;51(6):474–483. doi:10.1310/hpj5106-474. - DOI - PMC - PubMed